Cambodia vs Zimbabwe: HIV-positive TB patients on ART (antiretroviral therapy)
Cambodia
96.0%
in 2024
Zimbabwe
96.0%
in 2024
Cambodia rank
74th
Zimbabwe rank
74th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Cambodia
- Zimbabwe
How they compare
Cambodia currently reports 96.0% against 96.0% in Zimbabwe, a difference of 0.0%.
The two have swapped places 4 times across 18 shared years of data; in 2007 it was Zimbabwe ahead.
Cambodia ranks 74th and Zimbabwe ranks 74th of 144 countries.
Across the 3 decades both report, Cambodia averaged higher in 1 and Zimbabwe in 2.
Head to head by decade
| Decade | Cambodia | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.0% | 29.7% | 13.7% | Zimbabwe |
| 2010s | 88.0% | 77.7% | 10.3% | Cambodia |
| 2020s | 94.2% | 94.4% | 0.2% | Zimbabwe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Cambodia or Zimbabwe?
- Cambodia, at 96.0% against 96.0% in Zimbabwe as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Cambodia and Zimbabwe?
- 0.0%, with Cambodia ahead.
- How many years of comparable data are there for Cambodia and Zimbabwe?
- 18 years are reported by both, from 2007 to 2024.
- How do Cambodia and Zimbabwe rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Cambodia ranks 74th and Zimbabwe ranks 74th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.